mitochondria and oxidative damage to the nucleus. Am J Pathol
153:447– 456.
Bancroft JD, Stevens A (1996) Theory and practice of histological techniques. Fourth edition, New York: Churchill-Livingstone.
Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357–366.
C laycamp HG (1992) Phenol sensitization of DNA to subsequent oxidative damage in 8-hydroxyguanine assays. Carcinogenesis
13:1289 –1292.
Collins AR, Dusinska M, Gedik CM, Stetina R (1996) Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect
104[Suppl 3]:465– 469.
Colurso GJ, Kan RK, Anthony A (1995) Microdensitometric measures
of cytoplasmic RNA and total protein in pyramidal neurons of the
insular cortex and midfrontal gyrus in patients with Alzheimer's disease. C ell Biochem Funct 13:287–292.
Dani SU (1997) Molecular turnover and aging. In: Principles of neural
aging (Dani SU, Hori A, Walter GF, eds), pp 83–101. Amsterdam:
Elsevier.
Davison AN (1981) Biochemistry of the nervous system. In: The molecular basis of neuropathology (Davison AN, Thompson RHS, eds), pp
1–13. L ondon: Arnold.
Fiala ES, Conaway CC, Mathis JE (1989) Oxidative DNA and RNA
damage in the livers of Sprague Dawley rats treated with the hepatocarcinogen 2-nitropropane. C ancer Res 49:5518 –5522.
Floyd RA, West MS, Eneff KL, Schneider JE, Wong PK, Tingey DT,
Hogsett WE (1990) Conditions influencing yield and analysis of
8-hydroxy-2'-deoxyguanosine in oxidatively damaged DNA. Anal Biochem 188:155–158.
Ginsberg SD, Crino PB, Lee VM-Y, Eberwine JH, Trojanowski JQ
(1997) Sequestration of RNA in Alzheimer's disease neurofibrillary
tangles and senile plaques. Ann Neurol 41:200 –209.
Giuffrida AM (1983) Nucleic acids in developing brain. In: Handbook of
neurochemistry, Vol 5, Metabolic turnover in the nervous system, 2nd
Ed (Lajtha A, ed), pp 227–250. New York: Plenum.
Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996) Evidence for
neuronal oxidative damage in Alzheimer's disease. Am J Pathol
149:21–28.
Helbock HJ, Beckman K B, Shigenaga M K , Walter PB, Woodall AA,
Yeo HC, Ames BN (1998) DNA oxidation matters: the HPLCelectrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxogaunine. Proc Natl Acad Sci USA 95:288 –293.
Joenje H (1989) Genetic toxicology of oxygen. Mutat Res 219:193–208.
K hachaturian Z S (1985) Diagnosis of Alzheimer's disease. Arch Neurol
42:1097–1105.
Mann DMA, Neary D, Yates PO, Lincoln J, Snowden JS, Stanworth P
(1981) Alterations in protein synthetic capability of nerve cells in
Alzheimer's disease. J Neurol Neurosurg Psychiatry 44:97–102.
Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134 –147.
Masliah E, Terry RD, Alford M, DeTeresa R (1990) Quantitative im- munohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin
sections. J Histochem Cytochem 38:837–844.
Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal M F (1993) Oxidative damage to mitochondrial DNA
shows marked age-dependent increases in human brain. Ann Neurol
34:609 – 616.
Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol
36:747–751.
Mecocci P, Beal M F, C ecchetti R, Polidori MC, Cherubini A, Chionne F,
Avellini L, Romano G, Senin U (1997) Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD
human brain. Mol Chem Neuropathol 31:53– 64.
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM,
Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to
establish a registry for Alzheimer's disease (CER AD). II. Standardization of the neuropathologic assessment of Alzheimer's disease.
Neurology 41:479 – 486.
Montine TJ, Amarnath V, Martin M E, Strittmatter WJ, Graham DG
(1996) E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal
proteins in P19 neuroglial cultures. Am J Pathol 148:89 –93.
